Pierre DillenbourgAncien instituteur primaire, Pierre Dillenbourg obtient un master en Sciences de lEducation (Université de Mons, Belgique). Dans son projet de master en 1986, il est l'un des premiers au monde à appliquer les méthodes de 'machine learning' à l'éducation, afin de développer un 'self-improving teaching system'. Ceci lui permettra de débuter une thèse de doctorat en informatique à l'Université de Lancaster (UK) dans le domaine des applications éducatives de lintelligence artificielle. Il a été Maître dEnseignement et de Recherche à lUniversité de Genève. Il rejoint l'EPFL en 2012, où Il fut le directeur du Centre de Recherche sur l'Apprentissage, la formation et ses technologies(CRAFT), puis académique du Centre pour l'Education à l'Ere Digitale (CEDE) qui met en oeuvre la stratégie MOOC de l'EPFL (plus de 2 millions d'inscriptions). Il est actuellement professeur ordinaire en technologies de formation aux sein de la faculté Informatique et Communications et dirige laboratoire d'ergonomie éducative (CHILI). Depuis 2006, il a aussi été le directeur de DUAL-T, la 'leading house' dédiée aux technologies pour les systèmes de formation professionnelle duale. Il a fondé plusieurs start-ups dans l'éducation et rejoint plusieurs conseils d'administration. En 2017, Il a créé avec des collègues le 'Swiss EdTech Collider', un incubateur qui rassemble 80 start-ups dans le domaine des technologies éducatives. En 2018, ils ont lancé LEARN, le centre EPFL pour les sciences de l'apprentissage, lequel regroupe les initiatives locales en innovation éducative. Pierre est un 'inaugural fellow of the International Society of Learning Sciences'. Il est actuellement le Vice-Président Associé pour l'Education à l'EPFL.
Vincent KaufmannVincent Kaufmann is associate professor of urban sociology and mobility at Ecole Polytechnique Fédérale de Lausanne (EPFL). Since 2011, he is also scientific director of the Mobile Lives Forum in Paris. After a master degree in sociology (Universtiy of Geneva) he did his Ph.D. at EPFL on rationalities underlying transport modal practices. Vincent Kaufmann has been invited lecturer at Lancaster University (2000-2001), Ecole des Ponts et Chaussées, Paris (2001-2002), Laval University, Québec (2008) Nimegen University (2010), Université de Toulouse Le Mirail (2011), Université Catholique de Louvain (2004-2018) and Tongji University in Shanghai (2018). There fields of research are: motility, mobility and urban life styles, links between social and spatial mobility, public policies of land planning and transportation. He recently published “Mobilité et libre circulation en Europe” (with Ander Audikana) Economica (2017).
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.